AJB, PhD: 25 years big pharma, 6 years Academics, 5 yrs biotech, oncology, metabolic disease, medicinal chemistry.
HNB, PhD: 35+ years big pharma and academia, clinical pharmacology, pharmacokinetics, PK/PD modeling.
BMC: 32 years biotech & consulting, clinical development, regulatory, therapeutics, medical devices, ophthalmology, wound healing, dermatology, antibacterials.
LVC, PhD: 30+ years big pharma and academia, drug product development, formulation, regulatory processes.
JD, PhD: 30 years big pharma, global head, infectious diseases, med-chem, 30 clinical candidates, 8 compounds to the clinic.
DLH, MD, FACP, FIDSA: 31 years medical practice & big pharma (Merck, BMS), clinician, Phase 1-IV trial design, virology, antibacterials, antifungals.
SDL, PhD: 30 years big pharma (Pfizer, Pharmacia, Upjohn) and academia, med-chem, synthetic methodology, combinatorial chemistry, cardiovascular, diabetes, antivirals.
DM, PhD: 24 years big pharma, molecular modeling, CNS, cardiovascular; infectious diseases, 3 clinical candidates.
AMN, MD, PhD: 20 years biotech, immunology, inflammation, pharmacology, translational research.
RJP, PhD: 30 years big pharma, API management , process chemistry and manufacturing, and cost analysis, chemical development & API processes, CMO identification and management, small molecules and natural products.
WCS, PhD: Over 30 years in big pharma, CRO, and consulting, extensive experience in analytical development, formulation R&D, and CMC regulatory.
RJS, PhD: 20+ year academia, & pharma, cardiovascular, pharmacology, therapeutics, devices, diagnostics.
CPT, PhD: 27 years big pharma, CNS, pharmacology, neurological disorders, psychiatric disorders, pain, gabapentin, pregabalin.
JWT, PhD: 30 years biotech, biologics, process development, formulation, analytical development, CMC, lyophilization, and stability.
Testimonial: A quote from one of the opposition's attorneys after deposing one of IDSC's consultants, JD... "In my entire career as an attorney, I have never seen a witness that knows the prior art as well as you do."
IDSC brings our legal clients that big pharma perspective and our consultants have that hands on experience in therapeutic areas that are being prosecuted now and for the next decade.
Our legal clients come to us because our expert witnesses have lengthy careers exposing them to a great breadth and depth of information and expertise. They have the skill necessary to critically evaluate the prior art, apply it to the case in question, and explain it in layman's terms.
We bring the right fit for purpose witness: We bring a medicinal chemist to comment on medicinal chemistry, a biologist to comment on biology, a PK expert to comment on PK, a formulation expert to comment on formulation, and so on.
Our legal clients come to IDSC because our expert witnesses have the credentials to show credibility through extensive research, long term experience, publications, field of expertise, etc.
From the literature: A university professor with no patent experience weighing in on a genus... commented on the utility and breadth of genus. Witness was discredited.